NCT00599001View on ClinicalTrials.gov

Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

SD-101

Single subcutaneous escalating dose

DRUG

placebo

placebo

Trial Locations (1)

78209

Healthcare Discoveries, Inc., San Antonio

Sponsors
All Listed Sponsors
lead

Dynavax Technologies Corporation

INDUSTRY